Lyell Immunopharma

LYEL

12.9700.15% ( -0.020 )

Closed: Jul 29, 15:59:55 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Lyell Immunopharma(LYEL) predict that the Revenue is 2 K (-71.43%), Miss estimate;the EBIT is -44.26 M (+22.85%), Beat estimate;the EPS is -1.1 (+69.44%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

0.00B71.43%

0.00B37.14%

-0.00B34.29%

EBITExceed expectations

-0.04B22.85%

-0.05B6.12%

+0.01B16.73%

EPSExceed expectations

-1.169.44%

-2.36434.33%

+1.264035.11%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD